Vishal Khatri

493 total citations
33 papers, 366 citations indexed

About

Vishal Khatri is a scholar working on Infectious Diseases, Parasitology and Molecular Biology. According to data from OpenAlex, Vishal Khatri has authored 33 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 17 papers in Parasitology and 8 papers in Molecular Biology. Recurrent topics in Vishal Khatri's work include Parasitic Diseases Research and Treatment (22 papers), Parasites and Host Interactions (17 papers) and Insect symbiosis and bacterial influences (6 papers). Vishal Khatri is often cited by papers focused on Parasitic Diseases Research and Treatment (22 papers), Parasites and Host Interactions (17 papers) and Insect symbiosis and bacterial influences (6 papers). Vishal Khatri collaborates with scholars based in United States, India and Netherlands. Vishal Khatri's co-authors include Ramaswamy Kalyanasundaram, Nikhil Chauhan, Kalyan Goswami, Maryada Venkata Rami Reddy, M. V. R. Reddy, Perumal Kaliraj, Agneta von Gegerfelt, Kanchan Vishnoi, Prabhu Rajaiah Prince and Ara Arutunyan and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and The FASEB Journal.

In The Last Decade

Vishal Khatri

32 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vishal Khatri United States 14 203 180 110 87 51 33 366
Felicity E. Lumb United Kingdom 11 214 1.1× 110 0.6× 135 1.2× 54 0.6× 89 1.7× 14 384
Smitha Pillai Germany 7 242 1.2× 98 0.5× 122 1.1× 94 1.1× 133 2.6× 8 445
Jianzu Ding China 12 178 0.9× 60 0.3× 124 1.1× 101 1.2× 28 0.5× 25 365
Zilong Yu China 6 114 0.6× 33 0.2× 131 1.2× 59 0.7× 73 1.4× 9 291
S Dissanayake United Arab Emirates 11 141 0.7× 231 1.3× 47 0.4× 80 0.9× 29 0.6× 24 370
Amanda Gallagher United Kingdom 5 125 0.6× 49 0.3× 106 1.0× 67 0.8× 113 2.2× 6 361
Ximei Zhan China 11 92 0.5× 49 0.3× 46 0.4× 85 1.0× 79 1.5× 24 331
Carolyn A. Gray United Kingdom 9 149 0.7× 106 0.6× 52 0.5× 73 0.8× 203 4.0× 10 431
Xiang Nong China 10 79 0.4× 62 0.3× 104 0.9× 36 0.4× 16 0.3× 37 314
Cath Booth United Kingdom 3 164 0.8× 52 0.3× 87 0.8× 64 0.7× 100 2.0× 5 356

Countries citing papers authored by Vishal Khatri

Since Specialization
Citations

This map shows the geographic impact of Vishal Khatri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vishal Khatri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vishal Khatri more than expected).

Fields of papers citing papers by Vishal Khatri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vishal Khatri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vishal Khatri. The network helps show where Vishal Khatri may publish in the future.

Co-authorship network of co-authors of Vishal Khatri

This figure shows the co-authorship network connecting the top 25 collaborators of Vishal Khatri. A scholar is included among the top collaborators of Vishal Khatri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vishal Khatri. Vishal Khatri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khatri, Vishal, et al.. (2023). Methotrexate and sulforaphane loaded PBA-G5-PAMAM dendrimers as a combination therapy for anti-inflammatory response in an intra-articular joint arthritic animal model. International Journal of Pharmaceutics. 642. 123150–123150. 6 indexed citations
2.
Diepen, Angela van, D. Linh Nguyen, Erliyani Sartono, et al.. (2022). Mass Spectrometric and Glycan Microarray–Based Characterization of the Filarial Nematode Brugia malayi Glycome Reveals Anionic and Zwitterionic Glycan Antigens. Molecular & Cellular Proteomics. 21(5). 100201–100201. 17 indexed citations
3.
Khatri, Vishal, et al.. (2022). Pre-clinical development of a vaccine for human lymphatic filariasis. Frontiers in Tropical Diseases. 3. 2 indexed citations
4.
Khatri, Vishal, Nikhil Chauhan, & Ramaswamy Kalyanasundaram. (2020). Parasite Cystatin: Immunomodulatory Molecule with Therapeutic Activity against Immune Mediated Disorders. Pathogens. 9(6). 431–431. 22 indexed citations
5.
Khatri, Vishal, et al.. (2020). Peptide fragments of cystatin protein from filarial parasite has potent anti-inflammatory effect on DSS-induced colitis in mouse. The Journal of Immunology. 204(1_Supplement). 237.28–237.28. 2 indexed citations
6.
Khatri, Vishal, Nikhil Chauhan, & Ramaswamy Kalyanasundaram. (2020). Fecundity of adult female worms were affected when Brugia malayi infected Mongolian gerbils were immunized with a multivalent vaccine (rBmHAXT) against human lymphatic filarial parasite. Acta Tropica. 208. 105487–105487. 7 indexed citations
7.
Khatri, Vishal, et al.. (2020). Role of Glutathione in Chalcone Derivative Induced Apoptosis of Brugia malayi and its Possible Therapeutic Implication. Acta Parasitologica. 66(2). 406–415. 4 indexed citations
8.
Chauhan, Nikhil, et al.. (2020). Wuchereria bancrofti macrophage migration inhibitory factor‐2 (rWbaMIF‐2) ameliorates experimental colitis. Parasite Immunology. 42(4). e12698–e12698. 4 indexed citations
10.
Chauhan, Nikhil, et al.. (2018). Evaluating the Vaccine Potential of a Tetravalent Fusion Protein (rBmHAXT) Vaccine Antigen Against Lymphatic Filariasis in a Mouse Model. Frontiers in Immunology. 9. 1520–1520. 19 indexed citations
11.
Khatri, Vishal, et al.. (2017). Immunoprophylaxis of multi-antigen peptide (MAP) vaccine for human lymphatic filariasis. Immunologic Research. 65(3). 729–738. 13 indexed citations
12.
Khatri, Vishal, et al.. (2017). SXP–RAL Family Filarial Protein, rWbL2, Prevents Development of DSS-Induced Acute Ulcerative Colitis. Indian Journal of Clinical Biochemistry. 33(3). 282–289. 4 indexed citations
13.
Chauhan, Nikhil, et al.. (2017). Improving the efficacy of a prophylactic vaccine formulation against lymphatic filariasis. Parasitology Research. 116(10). 2821–2830. 17 indexed citations
14.
Khatri, Vishal, et al.. (2016). Immunization with Wuchereria bancrofti Glutathione-S-transferase Elicits a Mixed Th1/Th2 Type of Protective Immune Response Against Filarial Infection in Mastomys. Indian Journal of Clinical Biochemistry. 31(4). 423–430. 9 indexed citations
15.
Khatri, Vishal, et al.. (2016). Filarial Abundant Larval Transcript Protein ALT-2: An Immunomodulatory Therapeutic Agent for Type 1 Diabetes. Indian Journal of Clinical Biochemistry. 32(1). 45–52. 6 indexed citations
17.
Khatri, Vishal, et al.. (2015). Brugia malayisoluble and excretory‐secretory proteins attenuate development of streptozotocin‐induced type 1 diabetes in mice. Parasite Immunology. 37(12). 624–634. 13 indexed citations
18.
Khatri, Vishal, et al.. (2015). Immuno-Modulatory Effect and Therapeutic Potential of Brugia malayi Cystatin in Experimentally Induced Arthritis. Indian Journal of Clinical Biochemistry. 31(2). 203–208. 7 indexed citations
19.
Khatri, Vishal, et al.. (2015). Brugia malayi abundant larval transcript 2 protein treatment attenuates experimentally-induced colitis in mice.. PubMed. 53(11). 732–9. 8 indexed citations
20.
Swift, Luther, et al.. (2008). Controlled regional hypoperfusion in Langendorff heart preparations. Physiological Measurement. 29(2). 269–279. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026